9:40 AM
 | 
Nov 09, 2017
 |  BC Extra  |  Financial News

Apellis prices $150M IPO

Apellis Pharmaceuticals Inc. (NASDAQ:APLS) raised $150 million after market hours Wednesday through the sale of 10.7 million shares at $14 in an IPO underwritten by Citigroup, JPMorgan and Evercore. The...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >